Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
The American Healthcare Radiology Administrators (AHRA) organization is accepting award nominations for both its Gold Award and Fellow Status award for presentation at its 2004 annual conference August 1-5 in Boston.
Sony Electronics has shipped its first Professional Disc for DATA media, a recording technology that uses blue lasers -- instead of standard red lasers -- to write more data on a disc.
QuadraMed Corp.'s Affinity healthcare information system (HIS) and Quantim health information management (HIM) application suites are now available via a remote hosted option for customers seeking outsourced services.
Vital Images Inc.'s distribution agreement with Toshiba Medical Systems Corp. paid dividends in the first quarter, as the 3D software developer posted record revenues.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
